We report long time scale simulations of the 18-residue helical antimicrobial peptide ovispirin-1 and its analogs novispirin-G10 and novispirin-T7 in SDS micelles. The SDS micelle serves as an economical and effective model for a cellular membrane. Ovispirin, which is initially placed along a micelle diameter, diffuses out to the water-SDS interface and stabilizes to an interface-bound steady state in 16.35 ns of simulation. The final conformation, orientation, and the structure of ovispirin are in good agreement with the experimentally observed properties of the peptide in presence of lipid bilayers. The simulation succeeds in capturing subtle differences of the membrane-bound peptide structure as predicted by solid state NMR. The novispirins also undergo identical diffusion patterns and similar final conformations. Although the final interface-bound states are similar, the simulations illuminate the structural and binding properties of the mutant peptides which make them less toxic compared to ovispirin. Based on previous data and the current simulations, we propose that introduction of a bend/hinge at the center of helical antimicrobial peptides (containing a specific C-terminal motif), without disrupting the helicity of the peptides might attenuate host-cell toxicity as well as improve membrane binding properties to bacterial cellular envelopes.
Introduction
All animals possess evolutionarily ancient mechanisms for recognizing and resisting attack by microorganisms. Much of the immune resistance comes without the delay associated with the development of a complete specific immune response. Gene encoded antimicrobial peptides (AMPs) are now well known to be a pervasive component of the immune defense system all across the plant and animal kingdom. Research in this area has been galvanized by increasingly worrying reports of bacterial resistance to conventional antibiotics over the past two decades [23, 25, 31, 34] . The emergence of multi-drug resistant bacteria can lead to severe consequences like treatment failure and increased mortality. AMPs are being investigated as potential substitutes to con-ventional antibiotics in the hope of concocting novel antimicrobial agents to control antibiotic-resistant bacterial strains. Although it is fairly well established that AMPs lyse microbial cells by direct attack on the lipid bilayer of the inner cell membrane [6, 9] , the detailed molecular mechanism of action of most AMPs remains unclear. This lack of know-how has largely hampered the design of effective peptide antibiotics of therapeutic value.
Mammalian AMPs have been classified into cysteinerich (␣ or ␤) defensins and the cathelicidins. SMAP-29 is a 29-residue, helical bovine cathelicidin peptide with potent antimicrobial activity [12] . Kalfa and coworkers [12] systematically altered SMAP-29 to produce 23 related peptides. One of the peptides, ovispirin-1, was found to have significant antimicrobial activity against both Gram-positive and Gramnegative bacteria for a wide range of salt concentrations. Table 1 Representative functional properties of OVIS, G10 and T7
Ovispirin-1 (KNLRR IIRKI IHIIK KYG) resembles the first N-terminal 18 amino acids of SMAP-29 (RGLRR LGRKI
0196
Toxicity
Ovispirin-1 Novispirin-G10 Novispirin-T7 % Hemolysis (human RBCs) 70% at 80 g/ml 2.5% at 80 g/ml 10% at 80 g/ml % Cytotoxicity (cervical cells) 93.6% at 50 g/ml 5% at 50 g/ml 28.4% at 50 g/ml
Antimicrobial activity Minimum effective concentration (g/ml)
P. aeruginosa 1.66 (mean) 2.97 (mean) 4.64 (mean) S. aureus 1.0 ± 0.13 4.6 ± 1.7 3.3 ± 1.5 L. monocytogenes 1.5 ± 0.3 1.4 ± 0.4 2.4 ± 1.5
Data obtained from the work of Sawai et al. [28] .
AHGVK KYG) [12] . However, ovispirin-1, like SMAP-29, is unsuitable for therapeutic use owing to its hemolytic properties, which cause large-scale damage to human erythrocytes and epithelial cells. Sawai et al. [28] carried out single residue mutations in ovispirin-1 in an attempt to improve antimicrobial activity and subdue hemolytic properties. Residue 10 of ovispirin-1 was changed from isoleucine to glycine to make novispirin-G10 (KNLRR IIRKG IHIIK KYG). Residue 7 of ovispirin-1 was changed from isoleucine to threonine to make novispirin-T7 (KNLRR ITRKI IHIIK KYG). From now on, we will refer to the three peptides as OVIS, G10 and T7. Antimicrobial activity of the peptides was measured in terms of a minimum effective concentration using a radial diffusion assay. Hemolytic activity was measured in terms of percent hemoglobin released after a fixed-time incubation with the peptide. Table 1 lists the properties of the three peptides. It was found that both analogs of OVIS had reduced toxicity towards human cells. G10 is least toxic and has the best antibacterial properties [14] . The three dimensional structures of all three peptides in presence of tri-fluoro-ethanol (TFE) were evaluated from 2-D NMR. The point mutations led to significant structural changes in the peptides, inducing a helix kink in G-10 and N-terminal flexibility in T7 (Fig. 1) .
Notably, both mutations involve replacement of a hydrophobic residue with a residue with a non-hydrophobic side chain. Several studies have indicated that hydrophobicity is directly correlated to hemolytic and/or cytolytic properties in AMPs [15, 24] . Mellitin, a bee venom toxin, has been found to interact strongly with both neutral and negatively charged lipid bilayers [5] . This effect has been attributed to a highly hydrophobic N-terminus. Matsuzaki et al. hypothesized that magainin-2, a thoroughly examined helical AMP isolated from the skin of the frog Xenopus leavis, did not bind to zwitterionic mammalian membranes owing to the lack of hydrophobic residues [20, 21] . The postulation was vindicated by studies carried out by Tache et al. [30] where two magainin analogs with increased position-specific hydrophobicity were found to bind strongly to zwitterionic membranes. Conceivably, a higher presence of hydrophobic residues on helical peptides enhances their binding to mammalian eukaryotic membranes and leads to toxicity against host cells. This is a potentially important hypothesis which can chaperone the rational design of AMP analogs to attenuate their undesirable toxicity towards host cells. Indeed, this remains the essential goal of the very many mutational studies being carried out on AMPs with the overall objective of fabricating AMPs as antibiotics with potential clinical utility. However, despite the above knowledge, there are but rare instances of designs of better peptides achieved by simply reducing the hydrophobic content of native peptides. Indeed, these mutations must induce many other significant changes in the biophysical characteristics of the peptides, the molecular details of which are not well understood, and are not accessible by experiments. The primary objective of the current computational study is to evaluate the differential molecular interactions of the three peptides with model membrane assemblies in order to examine the overall comprehensive ramifications of mutations. Indeed, we have discovered that the role of such single residue mutations extends well beyond the superficiality of reducing overall hydrophobicity of the peptide.
We have carried out long time scale molecular dynamics (MD) simulations of each of the peptides in anionic sodium dodecylsulfate (SDS) micelles. We report the results from these simulations in the current article. Both SDS and diphosphocholine (DPC) micelles have been successfully modeled for MD simulations in CHARMM [19, 36] . The primary advantage of using micelles as opposed to lipid bilayers are the faster time scales of motion of SDS lipids. It has been shown both experimentally [8] and by molecular dynamics simulations [26, 35, 37] , that the slowest relaxation times of lipids in SDS and DPC micellar solutions are of the order of 500-1000 ps. The only exception to this is the slower relaxation times of counterions in simulations [19] . On the other hand, the area per lipid in model phospholipid bilayers relaxes on the order of 10s of nanoseconds, and the response of the bilayers to peptide insertion is relatively sluggish [29] . This is one of the principal reasons why there are only scattered efforts of simulations of AMPs with lipid bilayers. Single simulations of peptides in bilayers consume immense computational resources. The interaction of the peptide with the lipid macromolecular assembly induces a much faster response in micelles as opposed to bilayers. The micelle contains about half the number of atoms of a typical 128-lipid peptide-water bilayer simulation cell. This allows much longer simulations and permits monitoring of biological phenomena of longer time scales. Additionally, sometimes the simulations results can be directly compared to the experimental structures of the peptide, which are often determined in the presence of anionic and cationic detergents.
Simulations of micelles of various anionic and zwitterionic lipid micellar systems [2, 16, 19, 26, 29, 32, [35] [36] [37] [38] have been successfully used to interpret and supplement the information obtained from experimental methods like NMR, Xray diffraction, CD spectroscopy and FTIR spectroscopy. In the past few years, simulation force fields like CHARMM, AMBER and GROMACS have been fairly well parameterized to accurately simulate hydrated lipid assemblies. The current study focuses on the initial events involved in peptide binding on the micellar surface, stabilization/destabilization of the secondary structure, and the influence that the binding has on the micellar structure and dynamics. To our knowledge, this is the first set of long comparative simulations of a set of three related helical antimicrobial peptide analogs in a membrane-mimetic environment.
Methods
The starting coordinates of the SDS micelle-water complex were obtained from simulations carried out by MacKerell [19] . This structure was obtained after extensive minimization and 120 ps of NVT and NPT simulation in a cubic simulation cell. We placed the micelle consisting of 60 SDS molecules and 4375 waters in a cubic simulation box of cell size 54.15Å. Water was modeled using the TIP3P potential [11] . 60 sodium counterions, and 5 Na + and Cl − ions as 0.15 mM electrolyte were randomly distributed in the aqueous phase. The initial structure of peptides was obtained from the PDB databank (pdb ids: OVIS:1HU5, G10:1HU6, T7:1HU7). Solid state NMR experiments of OVIS [41] in lipid bilayers suggest that the OVIS helix sits parallel to the interface. However, we did not place the peptide at the SDS-water interface to avoid biasing the simulation towards the correct final conformation. Instead, each peptide was placed in the simulation box with its center of mass coinciding with that of the micelle. In this conformation, the peptide helix lay along one of the diameters of the micelle, with only its termini exposed to the solvent interface ( Fig. 2a  and c ). Owing to spherical symmetry of the micelle, the orientation of the peptide is unimportant. The fast dynamical time scales of SDS molecules ensured that the repositioning of the peptide to its final conformation would be computationally tractable. The side chains of lysines and arginines were protonated. Both the C-terminus and the N-terminus were charged. Thus, the peptide had a total charge of +7.
To remove initial bad contacts between the peptide and the SDS core, and prevent penetration of water during equilibration, the peptide and bulk water were kept under weak harmonic constraints with spring constants of 10 and 5 kcal/molÅ, respectively. The constraints were gradually removed in 20,000 steps of minimization (steepest descent method). The entire system was then minimized for 20,000 more steps without any constraints. Thereafter, the system consisting of about ∼16,000 atoms was gradually heated to 303 K. The entire assembly was subjected to NPT dynamics at pressure P = 1 atm and room temperature T = 303.15 K for at least 16 ns. The constant pressure-temperature module of CHARMM was used for the simulations with a leap-frog integrator. A time step of 2 fs was used. The temperature was set at 303.15 K using Hoover temperature control [10] . For the extended system pressure algorithm employed, all the components of the piston mass array were set to 500 amu [1, 27] . The electrostatic interactions were simulated using the particle mesh Ewald (PME) summation [3, 7] without truncation and a real space Gaussian width of 0.25Å −1 , a ␤-spline order of 4, and a FFT grid of about one point perÅ. SHAKE was used to eliminate the fastest degrees of freedom involving bonds with hydrogen atoms. All simulations were carried out using CHARMM version c29b2 with the param22 parameter set. The simulations were run on parallel processors on the Marvel Tru64 Unix clusters at the Pittsburgh Supercomputing Institute (PSC) and on the SGI Altix linux-based platforms at the Minnesota Supercomputing Institute (MSI). All three simulations were carried out for 16.35 ns, which is a total of nearly 50 ns of simulation. No previous simulations of peptides in SDS micelles have been carried out to this extent. Ensemble average properties were calculated for the last 2 ns of each simulation. For calculation of all dynamical properties, trajectories were sampled every 5 ps.
Results

Peptide position
As described in the Section 2, all ensemble averages have been taken for the last 2 ns of simulation. For dynamical properties, the trajectories were sampled every 5 ps.
In each of the three simulations, the peptide diffuses from the core of the micelle to an interface bound conformation which is energetically more favorable. The diffusion of the peptides occurs on the time scales of 8-12 ns. The initial and final conformations of OVIS w.r.t. the micelle are shown in Fig. 2 . G10 and T7 also have similar final binding conformations (see Fig. 6 ). Given that all three peptides are highly amphipathic (see later), it was to be expected that an embedded state in the micelle would be energetically unfavorable. Fig. 3 shows the temporal distance profile between the center of masses of the peptide and the micelle. In all three cases, the peptide traverses a distance of about 14Å, which closely corresponds to the radius of gyration of the micelle. The peptide thereafter remains bound to the interface and shows no sign of adopting a new conformation, position or orientation for a further ∼5 ns of simulation. We can safely assume that the interface-bound conformation of the peptide corresponds to its equilibrium state in the presence of the SDS membrane-mimetic (Fig. 4) .
The observed final conformation of OVIS is in excellent agreement with that predicted from solid state NMR [40] and the proton inverse detected deuteron (PRIDE) NMR technique [39] . In both experiments, the peptide was reconstituted in lipid vesicles composed of POPC:POPG lipids in the ratio 3:1. The latter is an anionic lipid. Both types of experiments indicate that ovispirin prefers to bind nearly parallel to the membrane-water interface (Fig. 5a ) (this corresponds to the final simulation conformation), and does not insert across the bilayer (this corresponds to the starting simulation configuration). It was also suggested from the experiments that the non-polar face of the OVIS helix in embedded into the lipid core (Fig. 5a ). Indeed, in the equilibrium conformation from simulations, the hydrophobic side chains of the peptide are anchored into the SDS core, while the polar face is exposed to the solvent interface (Fig. 6) . Thus with respect to peptide's equilibrium position and its orientation relative to the membrane interface, the simulation results comply with experimental observation. There are various instances in literature where peptides have been shown to orient at different angles with respect to the interface from simulations. For example, gp41 fusion peptide and its mutants oriented at angles varying from 40 • to 90 • in POPE bilayers [13] . The peptides magainin-2 and MSI-78 have been shown to orient at different angles (parallel to perpendicular) at POPC interfaces depending on different starting conformations of the peptide [14] .
In helical form, ovispirin demonstrates a conspicuous segregation of polar and non-polar residues into two topological halves. Fig. 5b shows a helical wheel diagram of the peptide. The polar half of the helix has a large number (seven) of positively charged residues. All lysines and arginines lie on the same half of the ovispirin helix. A subtle yet vital constituent of the electrostatic interactive forces is the cooperativity of the charged amino acid residues. Although the membrane surface is negatively charged, the accumulation of oppositely charged ions at the interface significantly attenuates the attractive electrostatic potential near a membrane [22] . In presence of a dielectric, the ion screening can reduce the electrostatic energy between two ions to as low as 3 kJ/mol, which is comparable to thermal fluctuation energies (kT) at room temperature. Thus, even in the vicinity of a negatively charged membrane, the kinetics of binding of a positively charged peptide will be dampened by thermal fluctuation. Yet, most AMPs can lyse bacterial cells on the time scales of minutes, which indicates that binding must be swift. The collective electrostatic attraction of all seven positively charged residues potentially accelerates binding kinetics, and allows the peptide to rapidly approach the membrane. The other helix face is hydrophobic, and after initial binding is complete, this part of the peptide will preferentially exclude solvent, and interact with the membrane hydrophobic core. The polar region is now exposed to the aqueous/interfacial phase.
T7 and G10 also share these amphipathic structural features with ovispirin. Indeed, their binding conformations are similar to ovispirin. In both cases, the hydrophobic region of the peptide is lodged into the SDS hydrophobic core. It is of note here, that all the three peptides possess strong antibacterial activity, and are expected to interact in the same manner with membrane assemblies containing a high proportion of anionic lipids. However, as a result of the point mutations, there are subtle differences in the interaction of the three peptides with the SDS core which shed light on the role of mutations towards the reduced toxicity and/or improved antibacterial activity of the mutants.
Peptide structure in the simulations
The NMR-derived structures (Fig. 1 ) of mutants T7 and G10 are different from OVIS [28] . In the presence of TFE, OVIS is a uniform helix from residues 4 to 16. T7 has a random-coil N-terminus and a reduced helix length: from residues 7 to 17. The presence of glycine in the G10 peptide leads to the formation of a hinge in the middle of the peptide which separates helices 5-11 and 14-16. The G10 peptide is conformationally most flexible. Although these structural features of the peptides remain mostly conserved during the course of the simulations, the presence of the micelle induces subtle adjustments in structure. The initial and final structures of all three peptides have been shown in Fig. 7 .
In TFE solutions, OVIS is a single helix all along the backbone [28] . However, this structure is not conserved in the presence of lipid bilayers. NMR spectra led to the hypothesis that the peptide might be bent at the C-terminus is order to facilitate better insertion into the lipid bilayer at that end [41] . The dihedral angle profiles of OVIS obtained from the simulations agree very well with the above hypothesis. The (ϕ, Fig. 6 . Final binding conformations of the three peptides. Snapshots were taken from two lateral perspectives after 16 ns of simulation. Hydrophobic residues have been shown in red, and basic residues have been shown in blue. SDS is in cyan wireframe. The binding conformation of ovispirin (a and b) are in excellent agreement with the experimentally predicted structure (Fig. 5a ). (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.) ψ) pair at positions 13 and 14 conform to the standard values for helices (−50, −60) for the initial structure of ovispirin in TFE as submitted in the pdb databank. However, the average (ϕ, ψ) values at these positions over the last 2 ns of simulation are (−70, 71) and (−70, 140): clearly deviant from a helical motif. Thus, the final membrane bound conformation of the peptide has a bend in the helix near the C-terminus, as predicted from NMR spectra. OVIS has a favorable hydrophobic gradient towards the C-terminus, and that end of the peptide is thus likely to be deeply inserted into the bilayer [41] . The bend in the molecule facilitates the C-terminal residues of the peptide to insert deeper into the bilayer, as hypothesized from experiments. Unfortunately, the spherical curvature of the SDS micelle does not allow us to visualize this preferential insertion explicitly. However, the simulations confirm that the helical bend predicted from NMR is indeed formed when the peptide encounters a membrane-like environment (Fig. 8) .
Interestingly, the TFE solution structure of G10 already has a bent C-terminus, courtesy of the glycine-induced hinge at positions 12 and 13. In OVIS, the bend is induced (partly) when the peptide encounters a membrane. It appears that the presence of the bend aids peptide binding to the membrane in either case. In case of G10, the bend is more pronounced and also leads to a significant angular offset in the two helical axes. During the course of simulation, the bend in G10 extends to positions 14 and 15 (Fig. 9 ). In the bound state, the section of the C-terminus which is purely helical is the region comprised of residues 16 (lysine) and 17 (tyrosine). The influences of the hinge region on peptide function and on micelle dynamics are discussed in more detail in later Section 3.3 .
The structure of T7 is mostly conserved from the beginning to the end of simulation. It continues to have a flexible N-terminus and a stable helix from positions 7 to 17 ( Fig. 10) . 
Pair distribution functions: Role of individual amino acids
All three peptides have seven positively charges residues: lysines in positions 1, 9, 15 and 16 and arginines in positions 4, 5 and 8. The positively charged centers on both side chains get associated with sulfate ions on SDS. In Fig. 11 , pair distribution functions (pdfs) between negatively charged centers on SDS (sulfur atom) and positively charged centers on the arginine and lysine residues have been constructed.
The strong electrostatic attraction between SDS and the amino acid side chains is manifest in the coincident sharp spikes in the pdfs. The pdfs unequivocally demonstrate that positively charged residues drive the binding of the peptide to the micellar surface. Although there are minor differences in the heights of the peaks for the first shell, the binding properties of the positively charged residues are similar for all three peptides, with the exception of lysine at position 15. Unlike in T7 or OVIS, the pdf of lysine in position 15 in G10 has a high peak. The insertion of a glycine residue in G10 results in the formation of two helices separated by a hinge at position 12-13. The hinge results in a twist in the G10 helix which allows the C-terminal Lys-15 to be significantly involved in electrostatic binding to the membrane. This is not possible with either T7 or with OVIS because no such explicit bend is formed. Additionally, the hinge also allows the aromatic ring of the tyrosine residue at position 17 to associate strongly with the micellar core as is evident from the pronounced peak in the pdfs constructed in Fig. 12 .
The implication of the insertion of the glycine residue in position 10 is thus not confined to reducing the hydrophobicity of the ovispirin helix (which was the primary objective of Sawai et al. [28] when making the mutation in the first place). It plays a more significant role in altering the structure of G10 so that the C-terminus of the peptide can bind strongly to the SDS core by means of both electrostatic and hydrophobic interactions. Other workers have found the same type of mutation leading to less toxic peptides. Recently, Lee et al. [18] modified IsCT (ILGKI WEGIK SLF), a noncell-selective 13 amino acid helical scorpion AMP by three mutations, one of which involved the introduction of proline for a glycine at position 8. The resulting peptide IsCT-1 (ILGKI WKPIK KLF) had a bend similar to G10. Indeed, this mutation did not involve removal of a hydrophobic residue, yet had much lower hemolytic and better antibacterial activity. Like the ovispirins, IsCT and its analog also have the same motif at the C-terminal helical turn: two positively charged residues (lysines) followed by an aromatic ring containing residue (phenylalanine). Remarkably, the simulations evidence that the helix hinge in G10 (at position 12) seem to Fig. 11 . Pair distribution functions between the sulfate head groups and the polar residues on the peptides. The x-axis is distance inÅ. For lysines and arginines, the positively charged centers on the side chains were used to draw the pdfs. For histidine and asparagine, all side chain heavy atoms were used. The pdfs were normalized by a density of 0.01 and by the number of atoms. Lys-15 is well associated with the sulfates in G10, but not so much in OVIS or T7. Fig. 12 . Pair distribution functions between the SDS core hydrocarbon atoms and the hydrophobic residues on the peptides. All side chain carbon atoms on the amino acids were used to draw the pdfs. The pdfs were normalized by a density of 0.01 and by the number of atoms. Tyr-17 in G10 has a strong preference to interact with the SDS core. Note the different y-axis scale for serve the same purpose as the hinge in IsCT (at position 9) observed experimentally: improve binding of the peptide's C-terminus to the membrane by a rotation of the helical axis mediated by a hinge. The improved binding of the peptide to the membrane is directly correlated to the improved activity of IsCT-1 and G10 compared to their parent peptides. Interestingly, Tossi et al.'s [33] 7-year-old design of a helical AMP 'PGG'based on sequence homology (GLLRR LRKKI GEIFK KYG) also carries the exact same motif: a glycine in the middle of the molecule, and positively charged residues followed by an aromatic amino acid at the C-terminus. It is highly probable that Tossi's consensus sequence functions the same way as G10 and IsCT. Apparently, in OVIS, the C-terminal bend only partially achieves this objective, as the tyrosine at position 17 or the lysine at position 15 do not exhibit a strong association with SDS (Fig. 13) .
The pair distribution functions at position 7 reveal some of the reasons behind the reduced toxicity of T7. As anticipated, it turns out that this is directly related to lesser number of hydrophobic residues present in T7 compared to OVIS. Thr-7 in T7 has a peak almost as sharp as other positively charged residues, indicating that the sulfates form stable H-bonds with the hydroxyl moiety of threonine at the interface. Position 7 in OVIS, on the other hand, is occupied by isoleucine, which prefers to localize inside the SDS core. Certainly, the replacement of Ile-7 by Thr-7 diminishes the ability of the peptide to interact with the hydrophobic core of the micelle. This argument becomes definitive from an opposite viewpoint. If we mutate T7 by the replacement of a polar (THR-7) residue for a hydrophobic (ILE) residue, the resulting peptide (OVIS) associates better with the hydrophobic core of a membrane. These non-polar binding forces become especially significant when the peptide binds to non-anionic mammalian membranes in the absence of direct cationicpeptide-anionic-membrane electrostatic forces. Fig. 13 . Pair distribution function of the SDS head group with peptide residues at position 7. For isoleucine, all non-backbone carbons were used. For threonine, all non-backbone carbons, and the hydroxyl oxygen were used. The pdfs were normalized by a density of 0.01 and by the number of atoms. This is an important inference, because it directly addresses and corroborates abundant experimental evidence wherein increased presence of hydrophobic residues has been shown to enhance host-cell (eukaryotic) toxicity and/or induce increased leakage from zwitterionic lipid vesicles [4, 5, 15, 20, 21, 24, 30] .
The same argument would also apply to position 10 in case of G10, where ILE-10 is replaced by GLY-10. However, in that case, the reduced hydrophobic binding at position 10 is largely offset by the increased association of the phenyl group at position 17.
Micelle structure and behavior
The placement of the peptide in the core of the SDS micelle in the starting conformation leads to numerous bad contacts. These steric overlaps disturb the structure and dynamics of the micelle in the initial phase of the simulations. In all three simulations, the micelle remains in a perturbed non-spherical state during the best of the first 9 ns of simulation. This is the time when the peptide diffuses out of the micelle interior to the interface. However, once the peptide approaches the steady state at the interface, the micelle structure equilibrates in the final 5-6 ns of simulation (Fig. 14) .
In order to monitor the equilibration, sphericity and structure of the micelle, we calculated the eccentricity of the micelle as [2] :
where I min is the moment of inertia along the x, y or z axes with the smallest magnitude, and I avg is the average of the three. For a perfect sphere, the eccentricity has a value of 0, and the deviation of the structure from perfect sphericity can be measured by monitoring the value of e. Fig. 15a shows the eccentricity of the micelle during the full course of the simulations. The presence of the peptide in the first 3 ns of the simulations causes the micelle to split into two halves separated by the peptide (Fig. 14) . This results in abnormally high values of e. However, the fluctuations become smaller and steadier for the last 5 ns of the simulation, when the peptide has diffused out of the micelle core. Thereafter, the micelle aggregates back to a more spherical shape in the final conformation. In all three cases, the final value of e hovers around 0.15. The ratios of moments of inertia in the x, y and z directions are also good estimates for monitoring micelle structure. As with the eccentricity, the ratios are high initially (indicating a more ellipsoidal shape) and stabilize to about 1.2 at the end of the simulations. Moment of inertia ratios ranging from 1.02 to 1.15 and eccentricities of 0.03 have been reported in previous simulations of pure SDS micelles carried out for different lengths of simulations time and different force fields (CHARMM [19] , AMBER [2, 26] ). Indeed, an eccentricity of 0.15 and an inertia ratio of 1.2 in our simulations indicate that the micelle deviates significantly from a perfectly spherical arrangement. This is owing to the presence of the peptide which forms strong hydrogen bonds with the SDS head groups, and also interacts with the micellar core by way of non-polar interactions. The two types of interactions apparently lead to localized rigidity in the micelle in the region abutting the peptide, causing a discontinuity in the symmetry of the biophysical forces which otherwise enable formation of a purely spherical micelle (Fig. 15) . The radius of gyration (R g ) of the micelle also stabilizes once the peptide diffuses out. A lower R g corresponds to a more spherical micelle. The equilibrium value in all three simulations is 15.5Å. For pure SDS micelles, the values reported in earlier simulations are 16Å [19] , 16.2Å [2] and 16.4Å [26] .
A careful look at the profiles for the R g and e reveal that the micelle remains more spherical and less perturbed in the G10 simulation, compared to T7 and OVIS. Apparently, the higher conformational flexibility of the G10 peptide allows it to emerge from the core of the micelle while causing lesser disarrangement of the micellar lipids.
The hydration of the micelle, as well as its deviation from a spherical structure can also be measured by its solvent exposed surface area. We calculated the Lee and Richards [17] surface area for the micelle with a probe radius of 1.4Å and an accuracy of 0.05. As anticipated, the surface area decreases during the course of the simulation, equilibrating to a value of 10,900Å 2 . Again, this represents a more spherical shape of the micelle as the simulations proceeds. All of the above results pertaining to the structure of the micelle independently attest that the micelle has reached its equilibrium conformation for all three simulations. Longer simulations are not necessary to observe any of the biophysical phenomena we are interested in, namely: binding of the peptides to the membrane mimetic, their final conformation and orientation, and the influence of the peptide on the structure of the micelle and vice versa.
Discussion
In the current work, we have reported long timescale molecular dynamics simulations of three similar helical antimicrobial peptides with SDS micelles. Despite starting from a peptide position far from the experimentally observed binding-conformation of OVIS in bilayers, the simulations converged to the correct final position, and the results are in excellent agreement with experimental data. Additional simulations with the mutant peptides G10 and T7 allow us to compare the biophysics of their differential peptide-membrane interactions, to help understand the determinants of their less toxic behavior. Amongst other things, we discover that the reduced hydrophobicity and the altered structure of these peptides are primarily responsible for a lower toxicity level compared to ovispirin. The mutation of an isoleucine to a threonine reduces the ability of the peptide to associate with the hydrophobic membrane core. The simulations also indicate that a glycine-induced bend in the middle of helical AMPs enables the C-terminal motif (two positively charged residues followed by an aromatic residue) of the peptide to associate better with the membrane mimic. There are other instances in literature where the same structural motif has been present, but has passed undetected. The current computational study helps uncover the function of this sequence and structural motif in AMPs which might be responsible for reduced toxicity of many helical AMPs.
It is commonly taken for granted that the structures of peptides in alcoholic solvents are the same as when bound to membranes. Previous short simulations (<3 ns) have illustrated that this may not be the case, and the change in structure has often been attributed to peptide-headgroup interactions; for an example, see Wymore and Wong [37] . Our 40 ns simulations also illustrate that the peptide structure from the simulations is different compared to the structures observed experimentally in organic solvents. As we have seen, the subtle differences in structural detail can have a significant influence on peptide function and activity. We thus need to exercise caution when making structure-activity-toxicity correlations based entirely on the solved structures of AMPs in aqueous or non-aqueous solvents. A better approach would be to solve the structures in better membrane-mimetic environments, and/or refine them with data available from simulations.
Although not as appropriate a model for a real membrane as a lipid bilayer, the SDS micelle captures the essential features which modulate peptide-membrane interaction. These are the presence of a strongly hydrophobic core, and a flexible polar interface capable of forming H-bonds and salt bridges with the solvent and the peptide, and also capable of responding dynamically to peptide-membrane interactions. The obvious advantages of using SDS are the faster time scale of motion and smaller system size which enables longer simulations. We expect that the remarkable diffusion of the peptide from the membrane core to the interface as observed in the micelle would not be observable in all atom models of lipid bilayers in the same time frame, due to the relative rigidity of membrane phospholipids.
To our knowledge, this is the first exhaustive set of simulations which addresses the molecular basis of innumerous attempts being made to design better antimicrobial peptidic molecules by means of modification of existing peptides. The current work demonstrates that simulations of different peptides under identical conditions sets up the basis for generating comparative molecular scale information which can be of immense help in interpreting experimental data, and helping understand atomic-scale physical interactions which result in slightly different peptides having vastly different cytotoxic and antibacterial activities. In the future, a rational comprehension of the role of these structural, biochemical and physical factors will be indispensable to the goal of designing AMPs which can have therapeutic value.
